Gastroenterology

Symptoms, Subtypes, and Biology: Understanding How EGE Works

At a Glance

Eosinophilic Gastroenteritis (EGE) has three main subtypes depending on how deep the inflammation goes: mucosal, muscularis, and serosal. The depth of the eosinophil buildup determines a patient's symptoms, ranging from diarrhea and malabsorption to severe bowel blockages or abdominal fluid buildup.

Understanding Eosinophilic Gastroenteritis (EGE) requires looking beneath the surface. Unlike many digestive issues that only affect the inner lining of the gut, EGE can impact different layers of the stomach and intestinal walls ^[1]. Where these eosinophils (allergic white blood cells) settle determines the symptoms you feel and the treatment approach your doctor may take.

The Three Subtypes of EGE

Doctors categorize EGE based on how deep the inflammation penetrates the tissue of your digestive tract ^[1].

1. The Mucosal Subtype (The Inner Lining)

This is the most common form of EGE ^[2]. The inflammation stays in the mucosa, the innermost layer that touches your food.

Symptoms: This subtype often leads to diarrhea, nausea, and abdominal pain ^[3].
Impact: Because the lining is inflamed, it cannot absorb nutrients properly (malabsorption), which can lead to weight loss or anemia ^[4]^[5].

2. The Muscularis Subtype (The Muscle Layer)

In this version, eosinophils infiltrate the muscle layer of the gut wall. This causes the wall to become stiff and thick ^[1].

Symptoms: The primary concern here is obstruction (a blockage). You might experience intense cramping, vomiting, or a feeling that food is “stuck” ^[6].
Impact: The thickened wall can interfere with motility—the natural wave-like motions that move food through your system ^[1].
⚠️ Medical Emergency Warning: A bowel obstruction can be life-threatening. Seek immediate emergency medical care if you experience sudden, severe abdominal pain, persistent vomiting, or an inability to pass gas or stool ^[6].

3. The Serosal Subtype (The Outer Layer)

This is the rarest form, where inflammation reaches the serosa, the outer coating of the organs ^[7].

Symptoms: This often causes ascites, which is a buildup of fluid in the abdominal cavity ^[8]. You may notice significant abdominal swelling, bloating, and pain ^[7]^[9].

The Biological Engine: Why the Buildup?

In a healthy body, eosinophils are “first responders” to parasites or allergens. In EGE, your immune system mistakenly keeps these cells on “high alert” in your gut ^[10].

Several biological messengers drive this process:

Cytokines (IL-4, IL-5, IL-13): These are chemical signals that tell the body to produce more eosinophils and keep them alive longer than usual ^[10]^[11]. IL-5 is particularly important, acting like a “magnet” that draws eosinophils into the tissue ^[12]. These specific signals are the targets of emerging biologic therapies (like dupilumab targeting IL-4/IL-13 or benralizumab targeting IL-5) ^[13].
Eotaxins: These are specific proteins (like CCL26) that guide eosinophils from your bloodstream into the lining of your stomach and intestines ^[14]^[15].
Barrier Dysfunction: Signals like TSLP can weaken the protective barrier of your gut, making it easier for allergens to trigger an inflammatory response ^[16].

Structural vs. Functional: It’s Not “Just IBS”

Because EGE causes pain, bloating, and diarrhea, it is often mistaken for Irritable Bowel Syndrome (IBS) or GERD (reflux) ^[17]^[18]. However, there is a fundamental difference:

Functional Disorders (like IBS): The gut looks healthy under a microscope, but it isn’t moving or “communicating” correctly with the brain.
Structural/Inflammatory Disorders (like EGE): There is visible, measurable damage and a physical buildup of inflammatory cells ^[5].

While IBS treatments focus on managing nerve sensitivity or stress, EGE treatments focus on calming the immune system and removing the triggers that cause eosinophils to attack the tissue ^[2]^[19].

Common questions in this guide

What are the three subtypes of Eosinophilic Gastroenteritis?

The three subtypes of EGE are mucosal, muscularis, and serosal. They are categorized based on how deep the eosinophil inflammation penetrates the tissue of your digestive tract, which directly influences the types of symptoms you experience.

What are the symptoms of mucosal EGE?

Mucosal EGE affects the innermost lining of the gut and commonly causes diarrhea, nausea, and abdominal pain. Because the inflamed lining struggles to absorb nutrients, patients may also experience weight loss or anemia.

Why can the muscularis subtype of EGE be a medical emergency?

Muscularis EGE involves inflammation in the muscle layer of the gut wall, causing it to become stiff and thick. This can interfere with how food moves through your system and lead to a life-threatening bowel obstruction, which requires emergency medical care.

What is the serosal subtype of EGE?

Serosal EGE is the rarest form of the disease and occurs when inflammation reaches the outer coating of the digestive organs. It typically causes ascites, which is a noticeable and painful buildup of fluid in the abdominal cavity.

How is EGE different from Irritable Bowel Syndrome (IBS)?

While IBS is a functional disorder where the gut looks healthy under a microscope, EGE is a structural and inflammatory disorder. EGE involves visible tissue damage caused by a physical buildup of allergic white blood cells called eosinophils.

Curated prompts to bring to your next appointment.

1.Based on my symptoms and tests, which of the three subtypes (mucosal, muscular, or serosal) do you think I have?
2.Did my imaging or endoscopy show any 'thickening' of the bowel wall or signs of fluid buildup (ascites)?
3.Could my eosinophil counts be driven by a specific food allergy or environmental trigger?
4.If I have the muscular subtype, should I be on a liquid or modified-texture diet to avoid a blockage?
5.Does my blood work show high levels of eosinophils (peripheral eosinophilia), and how does that correlate with the inflammation in my gut?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (19)

1
Eosinophilic gastroenteritis: A case series of a rare disease from an apex Tertiary Care Center in South India.
Janardhanan S, James A, Palaniappan A, et al.
Annals of African medicine 2022; (21(4)):461-465 doi:10.4103/aam.aam_130_21.
PMID: 36412352
2
Eosinophilic gastroenteritis in an adolescent male with history of chronic bullous disease.
Tan-Lim CSC, Murillo JML, Recto MST, Castor MAR
BMJ case reports 2021; (14(2)) doi:10.1136/bcr-2020-238532.
PMID: 33541980
3
Eosinophilic gastroenteritis as a cause of gastrointestinal tract bleeding and protein-losing enteropathy.
Eren M, Uluğ N, Aydemir Y
Turk pediatri arsivi 2020; (55(3)):299-303 doi:10.14744/TurkPediatriArs.2018.48376.
PMID: 33061759
4
Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience.
Kennedy K, Muir AB, Grossman A, et al.
The journal of allergy and clinical immunology. In practice 2019; (7(6)):2059-2061 doi:10.1016/j.jaip.2019.01.053.
PMID: 30763733
5
Eosinophilic gastroenteritis - a manifestation of an allergic disease in the gastrointestinal tract? Part 1. Epidemiology and diagnosis.
Kuźmiński A, Rosada T, Przybyszewska J, et al.
Przeglad gastroenterologiczny 2023; (18(1)):43-46 doi:10.5114/pg.2022.118634.
PMID: 37007757
6
Eosinophilic gastroenteritis: Imaging spectrum on intestinal ultrasonography and CT enterography.
Ma L, Li W, Xiao M, et al.
European journal of radiology 2024; (181()):111820 doi:10.1016/j.ejrad.2024.111820.
PMID: 39536481
7
Eosinophilic gastroenteritis without identifiable allergens in an adult: A case report.
Lan H, Yang T, Zhou L, et al.
SAGE open medical case reports 2025; (13()):2050313X241312935 doi:10.1177/2050313X241312935.
PMID: 39906476
8
Eosinophilic ascites and enteritis: a neglected case report from Vietnam.
Huynh TM, Vu NTH, Vo TTL, et al.
The Journal of international medical research 2024; (52(9)):3000605241277401 doi:10.1177/03000605241277401.
PMID: 39238276
9
Eosinophilic Gastroenteritis: Using Presenting Findings to Predict Disease Course.
Havlichek D, Choung RS, Murray JA
Clinical and translational gastroenterology 2021; (12(10)):e00394 doi:10.14309/ctg.0000000000000394.
PMID: 34620754
10
Hematopoietic prostaglandin D synthase: Linking pathogenic effector CD4(+) T(H)2 cells to proeosinophilic inflammation in patients with gastrointestinal allergic disorders.
Wen T, Rothenberg ME, Wang YH
The Journal of allergy and clinical immunology 2016; (137(3)):919-21.
PMID: 26947983
11
Future therapies for eosinophilic gastrointestinal disorders.
Pesek RD, Gupta SK
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2020; (124(3)):219-226 doi:10.1016/j.anai.2019.11.018.
PMID: 31778820
12
A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis.
Bitton A, Avlas S, Reichman H, et al.
Science immunology 2020; (5(44)) doi:10.1126/sciimmunol.aaw2938.
PMID: 32060143
13
The Unusual Clinical Presentation of Eosinophilic Gastroenteritis and Its Response to Mepolizumab: Two Case Reports.
Kiblawi MA, Malik T, Edan MM
Cureus 2024; (16(10)):e72589 doi:10.7759/cureus.72589.
PMID: 39610640
14
Circumferential Stenosis of the Second Part of the Duodenum Caused by Eosinophilic Gastroenteritis.
Honjo H, Minaga K, Hara A, et al.
Internal medicine (Tokyo, Japan) 2024; (63(8)):1087-1092 doi:10.2169/internalmedicine.2464-23.
PMID: 37661445
15
CCR3-dependent eosinophil recruitment is regulated by sialyltransferase ST3Gal-IV.
Immler R, Nussbaumer K, Doerner A, et al.
Proceedings of the National Academy of Sciences of the United States of America 2024; (121(19)):e2319057121 doi:10.1073/pnas.2319057121.
PMID: 38687790
16
Abnormal thymic stromal lymphopoietin expression in the gastrointestinal mucosa of patients with eosinophilic gastroenteritis.
Guo H, Ji X, Yang G, Jin Y
Jornal de pediatria 2020; (96(3)):350-355 doi:10.1016/j.jped.2018.11.012.
PMID: 30763528
17
Diagnosis of eosinophilic gastroenteritis is easily missed.
Abassa KK, Lin XY, Xuan JY, et al.
World journal of gastroenterology 2017; (23(19)):3556-3564 doi:10.3748/wjg.v23.i19.3556.
PMID: 28596692
18
Unraveling the enigma of eosinophilic gastroenteritis: a rare case of multisystem involvement in an elderly patient.
Qadri HA, Sagar A, Zaman A, et al.
Oxford medical case reports 2026; (2026(2)):omaf302 doi:10.1093/omcr/omaf302.
PMID: 41716921
19
Evidence-Based and Emerging Diet Recommendations for Small Bowel Disorders.
Rej A, Potter MDE, Talley NJ, et al.
The American journal of gastroenterology 2022; (117(6)):958-964 doi:10.14309/ajg.0000000000001764.
PMID: 35404303

This page explains the symptoms and subtypes of Eosinophilic Gastroenteritis (EGE) for educational purposes. Always consult your gastroenterologist for an accurate diagnosis and personalized treatment plan.

Get notified when new evidence is published on Eosinophilic gastroenteritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents